. The photograph of tumors in sh-GFP and sh-Aurora B shRNA group. A, The photograph of HepG2 cells; B, the photograph of Hep3B cells. Figure S2 . Butein was identified through the compound screening. A, the structure of natural compounds used for screening. B, HepG2 cell lysates (400 mg) was incubated with compound-Sepharose 4B beads (Sepharose 4B beads only as control) overnight at 4°C, and the beads were subjected to western blotting. C, HepG2 cells were treated with 10 μM of natural compounds, cell viability was accessed by MTS assay. *, p<0.05. 
